Discovery could lead to better asthma treatment

April 21, 2016, Cardiff University
Obstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale Rosen/Wikipedia/CC BY-SA 2.0

Scientists have made a discovery that could lead to improved treatment for asthma sufferers.

They have found that blocking a certain signalling molecule can alleviate symptoms such as , swelling (edema), and constriction of the airways in the lungs.

The international study, led by Dr Stephan Caucheteux, from Cardiff University's School of Medicine, believes their work could ultimately help around the world.

Some 5.4m people in the UK are currently receiving treatment for asthma, including more than a million children.

The allergic immune response, which triggers the symptoms of asthma, is a complex process, which starts with the over-activation of a certain white blood cell, the allergen-specific helper T cells type 2.

"We found that by adding a , Interleukin 1 (IL-1) using an experimental model of , the symptoms would worsen dramatically," explained Dr Caucheteux.

"Therefore by blocking production of IL-1, we could alleviate the symptoms, such as mucus, swelling and constriction."

The research, published in the Journal of Allergy and Clinical Immunology, also involved colleagues at the National Institutes of Health in the USA: Drs Jane Hu-Li, Liying Guo, Michelle Crank, Nisan Bhattacharyya and Michael Collins.

This research project was directed by the late William E Paul, Chief of the Laboratory of Immunology at the National Institute of Allergy and Infectious Diseases.

Dr Jeff Zhu, Chief of the Molecular and Cellular Immunoregulation Unit at the Laboratory of Immunology at the National Institute of Allergy and Infectious Diseases, said: "The finding that IL-1 is involved in regulating the balance between inflammatory and anti-inflammatory Th2 cells has not only significantly enhanced our basic knowledge on T cell biology, but also provided a potentially effective and novel strategy to treat asthma."

Explore further: Blanket approach to asthma treatment not ideal, researchers find

More information: Interleukin-1 beta enhances inflammatory Th2 differentiation; Stephan M. Caucheteux; The Journal of Allergy and Clinical Immunology; DOI:

Related Stories

Blanket approach to asthma treatment not ideal, researchers find

October 7, 2015
University of Queensland research into the effects of dust mite and cockroach allergens has found that different types of asthma respond differently to a new experimental treatment.

Holiday health: Asthma with a side of allergies

November 8, 2013
People with asthma traveling to pet friendly homes for the holidays may want to pack allergy medication along with their inhaler. A study being presented this week at the American College of Allergy, Asthma and Immunology's ...

Allergy shots effective for baby boomers suffering from seasonal allergies

February 9, 2016
Recent years have seen an increase in those suffering from allergies, including baby boomers. And because older people tend to have additional chronic diseases, diagnosis and management of allergic rhinitis (hay fever) can ...

New asthma biomarkers discovered, could ease detection

April 13, 2016
People with asthma have telltale molecules circulating in their blood, say researchers at Penn State College of Medicine. The discovery could lead to the first diagnostic blood test for asthma, as well as more targeted treatments ...

Omalizumab decreases colds in inner-city children with asthma, study reports

March 6, 2016
Treatment with omalizumab significantly decreases the number of colds in inner-city children with allergic asthma, researchers reported at a press conference today at the American Academy of Allergy, Asthma and Immunology ...

Recommended for you

Bystander T cells can steal the show in resolving inflammation

March 23, 2018
In Type 1 diabetes the immune system mistakenly attacks and destroys insulin-producing pancreatic cells, leaving patients dependent on lifelong insulin injections. The putative perpetrators of the attack—which are called ...

Researchers discover a 'security chief' that sounds the alarm against infections

March 23, 2018
St. Jude Children's Research Hospital scientists have identified a key molecule that serves as a "security chief" to help the immune system quickly recognize and fight infections with dangerous gram-negative bacteria like ...

Whether the donor and recipient are male or female influences transplant rejection rates—investigators explore why

March 22, 2018
Biological sex differences can have far-reaching, clinical consequences, as illustrated by organ transplant outcomes. Men and women who receive donated organs can have different rates of transplant rejection, in some cases ...

Mumps resurgence likely due to waning vaccine-derived immunity

March 21, 2018
A resurgence of mumps in the U.S. among vaccinated young adults appears to be due to waning of vaccine-induced immunity, according to a new analysis from Harvard T.H. Chan School of Public Health. Researchers found that vaccine-derived ...

How allergens trigger asthma attacks

March 19, 2018
A team of Inserm and CNRS researchers from the Institute of Pharmacology and Structural Biology have identified a protein that acts like a sensor detecting allergens in the respiratory tract that are responsible for asthma ...

Single steroid-bronchodilator treatment for control and rescue improves persistent asthma

March 19, 2018
When it comes to treating teens and adults with persistent asthma, using a single corticosteroid and long-acting bronchodilator treatment for both daily asthma control and for rescue relief during sudden asthma attacks is ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.